Skip to content
011 322 44 56Monday – Friday 10 AM – 8 PM
Search:
Search
Linkedin page opens in new windowYouTube page opens in new window
Linkedin page opens in new windowYouTube page opens in new window
Mobilise-D
Mobilise-D
Mobilise-DMobilise-D
  • Mobilise-D IMI 2019-2024
    • Work Packages
    • Collaboration
    • Information PPIE Structures
    • PPAG Activities and Contributions
  • Resources
    • Publications
    • Promotion Resources
  • Mobilise-D Data & Algorithms
  • Patient Engagement
  • News
Search:
Search
Search:
Search
Mobilise-D Mobilise-D Mobilise-DMobilise-D
  • Mobilise-D IMI 2019-2024
    • Work Packages
    • Collaboration
    • Information PPIE Structures
    • PPAG Activities and Contributions
  • Resources
    • Publications
    • Promotion Resources
  • Mobilise-D Data & Algorithms
  • Patient Engagement
  • News
Linkedin page opens in new windowYouTube page opens in new window

Daily Archives: February 17, 2022

You are here:
  1. Home
  2. 2022
  3. February
  4. 17

Grosshansdorf is the first Mobilise-D site to reach their target number of participants in the clinical validation study

OtherBy Martin BergeFebruary 17, 2022

We are very proud to announce that the Pulmonary Research Institute (PRI) in Grosshandorf, Schleswig-Holstein, Germany, is the first clinical site in our ongoing Clinical Validation Study that has reached…

© 2019 Mobilise-D. All rights reserved.

Go to Top